Hamilton Health Sciences Corporation
Clinical trials sponsored by Hamilton Health Sciences Corporation, explained in plain language.
-
New device aims to stop strokes in High-Risk heart patients
Disease control Recruiting nowThis study tests if a catheter-based device that closes a small pouch in the heart (left atrial appendage) can prevent strokes or blood clots in people with atrial fibrillation who are already taking blood thinners. About 4000 participants at high risk of stroke will be enrolled.…
Phase: NA • Sponsor: Hamilton Health Sciences Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New ultrasound technique aims to save limbs in artery disease patients
Disease control Recruiting nowThis study tests whether using a tiny ultrasound camera inside the leg arteries during a procedure to open blockages can prevent major problems like amputation or the artery narrowing again. About 772 adults with severe peripheral artery disease (chronic limb-threatening ischemia…
Phase: NA • Sponsor: Hamilton Health Sciences Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can a simple drug stop dangerous bleeding in kidney patients during surgery?
Disease control Recruiting nowThis study tests whether giving two common drugs, tranexamic acid and desmopressin, before surgery can reduce bleeding in patients with chronic kidney disease or acute kidney injury. About 100 adults having noncardiac surgery will be randomly assigned to receive one or both drugs…
Phase: PHASE3 • Sponsor: Hamilton Health Sciences Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a diabetes drug tame a rare heart rhythm disorder?
Disease control Recruiting nowThis study tests a drug called tideglusib in 120 people with a genetic heart condition that can cause dangerous heart rhythms. The drug aims to reduce abnormal heartbeats and improve heart function. Participants will take either tideglusib or a placebo daily for about a year to s…
Phase: PHASE2 • Sponsor: Hamilton Health Sciences Corporation • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a single dye replace the standard two-step test for vulvar cancer spread?
Diagnosis Recruiting nowThis study compares a dye called ICG alone against the standard two-method approach (ICG plus a radioactive tracer) to find cancer in lymph nodes of women with early vulvar cancer. About 58 women will take part. If ICG alone works just as well, it could simplify surgery and reduc…
Sponsor: Hamilton Health Sciences Corporation • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Massive trial aims to slash infection risk in hip and knee replacements
Prevention Recruiting nowThis study tests if using antiseptic washes and placing antibiotics directly into the wound during hip or knee replacement surgery can lower the chance of a serious infection that requires another operation. Over 21,000 adults getting a joint replacement will be randomly assigned…
Phase: PHASE3 • Sponsor: Hamilton Health Sciences Corporation • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Could a simple injection cut pain after brain surgery?
Symptom relief Recruiting nowThis study tests whether injecting a numbing medication (bupivacaine) near a nerve cluster in the nose can reduce pain after minimally invasive pituitary tumor removal. About 108 adults will be randomly assigned to receive the nerve block, a placebo (saline), or no extra injectio…
Phase: PHASE4 • Sponsor: Hamilton Health Sciences Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Which neck surgery approach causes fewer side effects?
Knowledge-focused Recruiting nowThis study looks at two different surgical methods for anterior cervical spine surgery. Both use the same skin cut but differ in how the surgeon reaches the spine. The goal is to see if one approach leads to fewer problems with swallowing and voice changes. About 100 adults havin…
Sponsor: Hamilton Health Sciences Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC